Saturday, December 26, 2009

Gabapentina Combino Pharm




Gabapentina Combino Pharm may be available in the countries listed below.


Ingredient matches for Gabapentina Combino Pharm



Gabapentin

Gabapentin is reported as an ingredient of Gabapentina Combino Pharm in the following countries:


  • Spain

International Drug Name Search

Thursday, December 24, 2009

Dexanorm




Dexanorm may be available in the countries listed below.


Ingredient matches for Dexanorm



Repaglinide

Repaglinide is reported as an ingredient of Dexanorm in the following countries:


  • Indonesia

International Drug Name Search

Doxorubicin Hexal




Doxorubicin Hexal may be available in the countries listed below.


Ingredient matches for Doxorubicin Hexal



Doxorubicin

Doxorubicin hydrochloride (a derivative of Doxorubicin) is reported as an ingredient of Doxorubicin Hexal in the following countries:


  • Germany

International Drug Name Search

Thursday, December 17, 2009

Gran's Remedy




Gran's Remedy may be available in the countries listed below.


Ingredient matches for Gran's Remedy



Zinc Oxide

Zinc Oxide is reported as an ingredient of Gran's Remedy in the following countries:


  • New Zealand

International Drug Name Search

Friday, December 11, 2009

Triamtereen-Hydrochloorthiazide Sandoz




Triamtereen-Hydrochloorthiazide Sandoz may be available in the countries listed below.


Ingredient matches for Triamtereen-Hydrochloorthiazide Sandoz



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Triamtereen-Hydrochloorthiazide Sandoz in the following countries:


  • Netherlands

Triamterene

Triamterene is reported as an ingredient of Triamtereen-Hydrochloorthiazide Sandoz in the following countries:


  • Netherlands

International Drug Name Search

Thursday, December 10, 2009

Nirason




Nirason may be available in the countries listed below.


Ingredient matches for Nirason



Pentaerithrityl Tetranitrate

Pentaerithrityl Tetranitrate is reported as an ingredient of Nirason in the following countries:


  • Germany

International Drug Name Search

Monday, December 7, 2009

Tirentall




Tirentall may be available in the countries listed below.


Ingredient matches for Tirentall



Pentoxifylline

Pentoxifylline is reported as an ingredient of Tirentall in the following countries:


  • Georgia

International Drug Name Search

Béta Adalate




Béta Adalate may be available in the countries listed below.


Ingredient matches for Béta Adalate



Atenolol

Atenolol is reported as an ingredient of Béta Adalate in the following countries:


  • France

Nifedipine

Nifedipine is reported as an ingredient of Béta Adalate in the following countries:


  • France

International Drug Name Search

Wednesday, December 2, 2009

Czopki Glicerynowe




Czopki Glicerynowe may be available in the countries listed below.


Ingredient matches for Czopki Glicerynowe



Glycerol

Glycerol is reported as an ingredient of Czopki Glicerynowe in the following countries:


  • Poland

International Drug Name Search

Friday, November 27, 2009

Carvil




Carvil may be available in the countries listed below.


Ingredient matches for Carvil



Carvedilol

Carvedilol is reported as an ingredient of Carvil in the following countries:


  • Bangladesh

  • India

  • Myanmar

International Drug Name Search

Saturday, November 21, 2009

Amosulalol




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0085320-68-9

Chemical Formula

C18-H24-N2-O5-S

Molecular Weight

380

Therapeutic Categories

ß-Adrenergic blocking agent

Antihypertensive agent

α-Adrenergic blocking agent

Chemical Name

(±)-5-(1-Hydroxy-2-[[2-(o-methoxyphenoxy)ethyl]amino]ethyl)-o-toluenesulfonamide

Foreign Names

  • Amosulalolum (Latin)
  • Amosulalol (German)
  • Amosulalol (French)
  • Amosulalol (Spanish)

Generic Name

  • YM 09538 (IS: Yamanouchi)

Brand Name

  • Lowgan
    Astellas, Japan

International Drug Name Search

Glossary

ISInofficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, November 18, 2009

Perkinil




Perkinil may be available in the countries listed below.


Ingredient matches for Perkinil



Procyclidine

Procyclidine hydrochloride (a derivative of Procyclidine) is reported as an ingredient of Perkinil in the following countries:


  • Bangladesh

International Drug Name Search

Oxigen




Oxigen may be available in the countries listed below.


Ingredient matches for Oxigen



Nimodipine

Nimodipine is reported as an ingredient of Oxigen in the following countries:


  • Brazil

International Drug Name Search

Saturday, November 14, 2009

Eplon




Eplon may be available in the countries listed below.


Ingredient matches for Eplon



Zaleplon

Zaleplon is reported as an ingredient of Eplon in the following countries:


  • Bangladesh

  • Myanmar

International Drug Name Search

Monday, November 9, 2009

Zimor




Zimor may be available in the countries listed below.


Ingredient matches for Zimor



Omeprazole

Omeprazole is reported as an ingredient of Zimor in the following countries:


  • Singapore

  • Spain

Zolpidem

Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Zimor in the following countries:


  • Colombia

International Drug Name Search

Monday, October 26, 2009

Diltiazem Biogaran




Diltiazem Biogaran may be available in the countries listed below.


Ingredient matches for Diltiazem Biogaran



Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Diltiazem Biogaran in the following countries:


  • France

International Drug Name Search

Saturday, October 17, 2009

Clorpropamida L.CH.




Clorpropamida L.CH. may be available in the countries listed below.


Ingredient matches for Clorpropamida L.CH.



Chlorpropamide

Chlorpropamide is reported as an ingredient of Clorpropamida L.CH. in the following countries:


  • Chile

International Drug Name Search

Thursday, October 15, 2009

Amiodarone-Merck




Amiodarone-Merck may be available in the countries listed below.


Ingredient matches for Amiodarone-Merck



Amiodarone

Amiodarone hydrochloride (a derivative of Amiodarone) is reported as an ingredient of Amiodarone-Merck in the following countries:


  • Luxembourg

International Drug Name Search

Thursday, October 8, 2009

Salazopyrin EN-Tabs




Salazopyrin EN-Tabs may be available in the countries listed below.


Ingredient matches for Salazopyrin EN-Tabs



Sulfasalazine

Sulfasalazine is reported as an ingredient of Salazopyrin EN-Tabs in the following countries:


  • Ireland

  • Lithuania

International Drug Name Search

Pronor




Pronor may be available in the countries listed below.


Ingredient matches for Pronor



Finasteride

Finasteride is reported as an ingredient of Pronor in the following countries:


  • Bangladesh

International Drug Name Search

Saturday, October 3, 2009

Uroquidan




Uroquidan may be available in the countries listed below.


Ingredient matches for Uroquidan



Urokinase

Urokinase is reported as an ingredient of Uroquidan in the following countries:


  • Spain

International Drug Name Search

Thursday, September 24, 2009

Tenacid




Tenacid may be available in the countries listed below.


Ingredient matches for Tenacid



Cilastatin

Cilastatin sodium salt (a derivative of Cilastatin) is reported as an ingredient of Tenacid in the following countries:


  • Italy

Imipenem

Imipenem monohydrate (a derivative of Imipenem) is reported as an ingredient of Tenacid in the following countries:


  • Italy

International Drug Name Search

Friday, September 18, 2009

Hexanurat




Hexanurat may be available in the countries listed below.


Ingredient matches for Hexanurat



Allopurinol

Allopurinol is reported as an ingredient of Hexanurat in the following countries:


  • Denmark

International Drug Name Search

Wednesday, September 9, 2009

Paraclim




Paraclim may be available in the countries listed below.


Ingredient matches for Paraclim



Tibolone

Tibolone is reported as an ingredient of Paraclim in the following countries:


  • Argentina

International Drug Name Search

Tuesday, September 8, 2009

Rinderon Eye Drop




Rinderon Eye Drop may be available in the countries listed below.


Ingredient matches for Rinderon Eye Drop



Betamethasone

Betamethasone 21-(disodium phosphate) (a derivative of Betamethasone) is reported as an ingredient of Rinderon Eye Drop in the following countries:


  • Taiwan

International Drug Name Search

Monday, September 7, 2009

Equeta




Equeta may be available in the countries listed below.


Ingredient matches for Equeta



Quetiapine

Quetiapine fumarate (a derivative of Quetiapine) is reported as an ingredient of Equeta in the following countries:


  • Slovakia

International Drug Name Search

Tuesday, August 11, 2009

Atacand




In the US, Atacand (candesartan systemic) is a member of the drug class angiotensin II inhibitors and is used to treat Heart Failure and High Blood Pressure.

US matches:

  • Atacand

  • Atacand HCT

  • Atacand Oral

Ingredient matches for Atacand



Candesartan

Candesartan cilexetil (a derivative of Candesartan) is reported as an ingredient of Atacand in the following countries:


  • Algeria

  • Argentina

  • Aruba

  • Australia

  • Austria

  • Bahamas

  • Bahrain

  • Barbados

  • Belgium

  • Bermuda

  • Brazil

  • Bulgaria

  • Canada

  • Chile

  • Colombia

  • Costa Rica

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Dominican Republic

  • Egypt

  • El Salvador

  • Estonia

  • Finland

  • France

  • Georgia

  • Germany

  • Ghana

  • Greece

  • Guatemala

  • Guyana

  • Haiti

  • Honduras

  • Hungary

  • Iceland

  • Ireland

  • Israel

  • Jamaica

  • Jordan

  • Kenya

  • Kuwait

  • Latvia

  • Lebanon

  • Lithuania

  • Luxembourg

  • Malaysia

  • Malta

  • Mexico

  • Netherlands

  • Netherlands Antilles

  • New Zealand

  • Nicaragua

  • Norway

  • Oman

  • Panama

  • Paraguay

  • Peru

  • Poland

  • Portugal

  • Qatar

  • Romania

  • Russian Federation

  • Saudi Arabia

  • Singapore

  • Slovakia

  • Slovenia

  • South Africa

  • South Korea

  • Spain

  • Sri Lanka

  • Sudan

  • Sweden

  • Switzerland

  • Trinidad & Tobago

  • Tunisia

  • Turkey

  • United Arab Emirates

  • United States

  • Uruguay

  • Venezuela

  • Zimbabwe

International Drug Name Search

Wednesday, July 15, 2009

Fosinorm




Fosinorm may be available in the countries listed below.


Ingredient matches for Fosinorm



Fosinopril

Fosinopril sodium salt (a derivative of Fosinopril) is reported as an ingredient of Fosinorm in the following countries:


  • Germany

International Drug Name Search

Monday, July 13, 2009

Beclometasona




Beclometasona may be available in the countries listed below.


Ingredient matches for Beclometasona



Beclometasone

Beclometasone is reported as an ingredient of Beclometasona in the following countries:


  • Argentina

  • Peru

Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Beclometasona in the following countries:


  • Chile

  • Ecuador

International Drug Name Search

Saturday, July 4, 2009

Fada Amoxicilina




Fada Amoxicilina may be available in the countries listed below.


Ingredient matches for Fada Amoxicilina



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Fada Amoxicilina in the following countries:


  • Argentina

International Drug Name Search

Friday, July 3, 2009

Crystalyx




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Crystalyx



Lasalocid

Lasalocid is reported as an ingredient of Crystalyx in the following countries:


  • United States

International Drug Name Search

Saturday, June 27, 2009

Cyclessa


Cyclessa is a brand name of desogestrel/ethinyl estradiol, approved by the FDA in the following formulation(s):


CYCLESSA (desogestrel; ethinyl estradiol - tablet; oral-28)



  • Manufacturer: ORGANON USA INC

    Approval date: December 20, 2000

    Strength(s): 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG [RLD][AB]

Has a generic version of Cyclessa been approved?


Yes. The following products are equivalent to Cyclessa:


DESOGESTREL AND ETHINYL ESTRADIOL (desogestrel; ethinyl estradiol tablet; oral-28)



  • Manufacturer: WATSON LABS

    Approval date: January 24, 2006

    Strength(s): 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG [AB]

VELIVET (desogestrel; ethinyl estradiol tablet; oral-28)



  • Manufacturer: DURAMED PHARMS BARR

    Approval date: February 24, 2004

    Strength(s): 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cyclessa. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Cyclessa.

See also...

  • Cyclessa Consumer Information (Cerner Multum)
  • Desogestrel/Ethinyl Estradiol Consumer Information (Wolters Kluwer)
  • Ethinyl estradiol and desogestrel Consumer Information (Cerner Multum)

Sunday, June 21, 2009

Asmanex Twisthaler


Asmanex Twisthaler is a brand name of mometasone, approved by the FDA in the following formulation(s):


ASMANEX TWISTHALER (mometasone furoate - powder; inhalation)



  • Manufacturer: SCHERING

    Approval date: March 30, 2005

    Strength(s): 0.22MG/INH [RLD]


  • Manufacturer: SCHERING

    Approval date: February 1, 2008

    Strength(s): 0.11MG/INH

Has a generic version of Asmanex Twisthaler been approved?


No. There is currently no therapeutically equivalent version of Asmanex Twisthaler available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Asmanex Twisthaler. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Inhalation device for powdered medicaments
    Patent 5,394,868
    Issued: March 7, 1995
    Inventor(s): Ambrosio; Thomas J. & Manthena; Srinivas & Sochon; Henry R.
    Assignee(s): Schering Corporation
    A powder dispenser 10 includes a powder housing 28 for holding a supply of powdered material to be dispensed, the powder housing including a first conduit 32 extending there through in displaced relation to the powdered material; a metering plate 16 having only a single receptacle area 24 for holding a metered amount of the powdered material above a gas-permeable powder retainer 26 mounted at the metering plate, and being positioned below the powdered material, and the metering plate and the powder housing being rotatable with respect to each other so that the receptacle area is adapted to be in selective communication with the supply of powdered material or the first conduit; a base housing 48 being mounted below the metering plate and including a second conduit 52 in alignment with the first conduit at least concurrently with alignment of the receptacle area and the first conduit; a spring 62 for biasing the base housing and the powder housing toward each other; a mouthpiece 92 for enabling inhalation of the metered amount of powdered material from the receptacle area in the metering plate through the first conduit in the container, the mouthpiece being in fluid communication with the first conduit.
    Patent expiration dates:

    • June 25, 2012
      ✓ 
      Drug product


    • December 25, 2012
      ✓ 
      Pediatric exclusivity




  • Inhaler for powdered medications having spiral deagglomeration chamber
    Patent 5,687,710
    Issued: November 18, 1997
    Inventor(s): Ambrosio; Thomas J. & Bilanin; Alan J. & Kaufman; Andrew E. & Kenyon; David J. & Manthena; Srinivas & Yang; Tsong-Toh
    Assignee(s): Schering Corporation
    A powder dispenser includes a powder housing for holding a supply of powdered material to be dispensed, the powder housing including an inhalation conduit provided displaced relation to the powdered material supply; a metering plate including a metered dose hole for holding a metered amount of the powdered material, and positioned below the powdered material supply, the metering plate and the powder housing being relatively rotatable with respect to each other about a common central axis; a counter providing a visual count of the number of doses of the powdered material that have been dispensed or remain to be dispensed in response to the relative rotation, the counter including counter rings providing the visual count, the counter rings being rotatable about the common central axis and having indicia thereon which display the visual count, and an actuating mechanism rotatable about the central axis for incrementally rotating the counter rings in response to the relative rotation; a nozzle for breaking up agglomerates of powdered material from the inhalation conduit to form micronized powdered material, the nozzle including a cavity for changing the direction of flow of the powder from the direction of the inhalation conduit to a second different direction, and a curved wall for substantially continuously changing the direction of flow of the powder in a spiral manner in the second direction in the cavity; and a closure cap covering the powder housing and priming the powder dispenser for use automatically upon removal thereof.
    Patent expiration dates:

    • November 18, 2014
      ✓ 
      Drug product


    • May 18, 2015
      ✓ 
      Pediatric exclusivity




  • Inhaler for powdered medications
    Patent 5,829,434
    Issued: November 3, 1998
    Inventor(s): Ambrosio; Thomas J. & Ashley; Charles R. & Bilanin; Alan J. & Huck; Charles M. & Kaufman; Andrew E. & Kenyon; David J. & Manthena; Srinivas & Sochon; Henry R. & Wilkinson; Ken & Yang; Tsong-Toh
    Assignee(s): Schering Corporation
    A powder inhaler comprising: a powder housing for holding a supply of powdered material to be dispensed and a metering plate for holding a metered amount of said powdered material, the metering plate being alternately positionable below said supply of powdered material or within an inhalation conduit, by means of a bi-directional, angle-limited relative rotation about a common central axis; a counter for providing a visual count of the number of doses of said powdered material that have been dispensed or remain to be dispensed in response to the relative rotation, the counter including: a continuous counter ring and a coaxially mounted intermittent counter ring, both rings being mounted on a base in surrounding relation to a retaining post, being rotatable about the common central axis and having counting indicia thereon for displaying said visual count; and a display means through which at least one of the counting indicia is displayed to indicate a count corresponding to a number of doses of powdered material that have been dispensed or remain to be dispensed.
    Patent expiration dates:

    • November 3, 2015
      ✓ 
      Drug product


    • May 3, 2016
      ✓ 
      Pediatric exclusivity




  • Use of mometasone furoate for treating lower airway passage and lung diseases
    Patent 5,889,015
    Issued: March 30, 1999
    Inventor(s): Sequeira; Joel A. & Cuss; Francis M. & Nolop; Keith B. & Chaudry; Imtiaz A. & Nagabhushan; Nagamani & Patrick; James E. & Cayen; Mitchell
    Assignee(s): Schering Corporation
    The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Patent expiration dates:

    • January 27, 2014
      ✓ 
      Patent use: TREATMENT OF ASTHMA


    • July 27, 2014
      ✓ 
      Pediatric exclusivity




  • Use of mometasone furoate for treating airway passage and lung diseases
    Patent 6,057,307
    Issued: May 2, 2000
    Inventor(s): Sequeira; Joel A. & Cuss; Francis M. & Nolop; Keith B. & Chaudry; Imtiaz A. & Nagabhushan; Nagamani & Patrick; James E. & Cayen; Mitchell
    Assignee(s): Schering Corporation
    The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Patent expiration dates:

    • January 27, 2014
      ✓ 
      Patent use: TREATMENT OF ASTHMA
      ✓ 
      Drug product


    • July 27, 2014
      ✓ 
      Pediatric exclusivity




  • Powdered medication inhaler
    Patent 6,240,918
    Issued: June 5, 2001
    Inventor(s): Ambrosio; Thomas J. & Benson, Jr.; Warren A. & Dao; Kim C. & Kenyon; David J. & Kreiseder; Walter J. & Schonebaum; Theodore J. & Vogel; Allen J. & Walker; Louis B. & Yang; Tsong-Toh
    Assignee(s): Schering Corporation
    A powder dispenser includes a reservoir body including a supply of powder and an inhalation conduit; a driving body for rotating the reservoir body and including upper recesses and two spring fingers in lower driving recesses thereof; a rotatable metering plate for carrying a metered amount of powder from the supply to the inhalation conduit, and having an underside with ribs; a gas permeable retainer welded to the ribs; a spring biasing the metering plate toward the reservoir body; a nozzle having spiked ribs welded in the upper recesses of the driving body and including a chimney with vertical flutes; an adapter non-rotatably mounted with respect to the metering plate and including two locking recesses for receiving the spring fingers for locking engagement and two helical cam tracks with a square cross-section; a closure cap covering the driving body and including priming ribs biasing the spring fingers out of the locking recesses and engaging with the locking recesses to rotate the driving body, and two cams riding within the cam tracks; a base non-rotatably connected with the metering plate; and a counter rotatably mounted on the base and including rotatable counter rings providing a visual count of the number of doses of powder to be dispensed, and a pawl assembly engaging with gear teeth of the counter rings for rotating the same, the pawl assembly including an outer wall, a pawl and a pawl spring integrally molded as a single piece.
    Patent expiration dates:

    • February 20, 2017
      ✓ 
      Drug product


    • August 20, 2017
      ✓ 
      Pediatric exclusivity




  • Use of mometasone furoate for treating airway passage and lung diseases
    Patent 6,365,581
    Issued: April 2, 2002
    Inventor(s): Joel A.; Sequeira & Francis M.; Cuss & Keith B.; Nolop & Imtiaz A.; Chaudry & Nagamani; Nagabhushan & James E.; Patrick & Mitchell; Cayen
    Assignee(s): Schering Corporation
    The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Patent expiration dates:

    • January 27, 2014
      ✓ 
      Patent use: TREATMENT OF ASTHMA


    • July 27, 2014
      ✓ 
      Pediatric exclusivity




  • Preparation of powder agglomerates
    Patent 6,503,537
    Issued: January 7, 2003
    Inventor(s): Tsong-Toh; Yang
    Assignee(s): Schering Corporation
    The invention relates to a method of producing an agglomerate of drug and solid binder. The process involves producing individual agglomerate particles and then converting the convertible amorphous content of same, following agglomeration, by the application of, for example, moisture. Agglomerates capable of conversion as well as the finished agglomerates and oral and nasal dosing systems including same are also contemplated. The process produces agglomerates which are rugged but which will produce an acceptable fine particle fraction during dosing.
    Patent expiration dates:

    • March 17, 2018
      ✓ 
      Drug product


    • September 17, 2018
      ✓ 
      Pediatric exclusivity




  • Use of mometasone furoate for treating airway passage and lung diseases
    Patent 6,677,322
    Issued: January 13, 2004
    Inventor(s): Joel A.; Sequeira & Francis M.; Cuss & Keith B.; Nolop & Imtiaz A.; Chaudry & Nagamani; Nagabhushan & James E.; Patrick & Mitchell; Cayen
    Assignee(s): Schering Corporation
    The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Patent expiration dates:

    • January 27, 2014
      ✓ 
      Patent use: TREATMENT OF ASTHMA


    • July 27, 2014
      ✓ 
      Pediatric exclusivity




  • Use of mometasone furoate for treating airway passage and lung diseases
    Patent 6,949,532
    Issued: September 27, 2005
    Inventor(s): Sequeira; Joel A. & Cuss; Francis M. & Nolop; Keith B. & Chaudry; Imtiaz A. & Nagabhushan; Nagamani & Patrick; James E. & Cayen; Mitchell
    Assignee(s): Schering Corporation
    The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Patent expiration dates:

    • January 27, 2014
      ✓ 
      Patent use: TREATMENT OF ASTHMA


    • July 27, 2014
      ✓ 
      Pediatric exclusivity



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • February 1, 2011 - NEW PATIENT POPULATION

See also...

  • Asmanex Consumer Information (Drugs.com)
  • Asmanex Twisthaler Powder Consumer Information (Wolters Kluwer)
  • Asmanex Twisthaler 120 Dose Consumer Information (Cerner Multum)
  • Asmanex Twisthaler 14 Dose Consumer Information (Cerner Multum)
  • Asmanex Twisthaler 30 Dose Consumer Information (Cerner Multum)
  • Asmanex Twisthaler 60 Dose Consumer Information (Cerner Multum)
  • Asmanex Twisthaler 7 Dose Consumer Information (Cerner Multum)
  • Asmanex Twist Advanced Consumer Information (Micromedex)
  • Asmanex Twisthaler Advanced Consumer Information (Micromedex)
  • Asmanex AHFS DI Monographs (ASHP)
  • Mometasone Powder Consumer Information (Wolters Kluwer)
  • Mometasone inhalation Consumer Information (Cerner Multum)
  • Azmax Twisthaler Advanced Consumer Information (Micromedex)
  • Mometasone Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)
  • Mometasone Furoate AHFS DI Monographs (ASHP)

Thursday, June 11, 2009

Histacetyl




Histacetyl may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Histacetyl



Dimetridazole

Dimetridazole is reported as an ingredient of Histacetyl in the following countries:


  • France

Spiramycin

Spiramycin is reported as an ingredient of Histacetyl in the following countries:


  • France

International Drug Name Search

Tuesday, June 9, 2009

Vanapen




Vanapen may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vanapen



Benzylpenicillin

Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Vanapen in the following countries:


  • Austria

International Drug Name Search

Sunday, June 7, 2009

Sucralfate




In some countries, this medicine may only be approved for veterinary use.


In the US, Sucralfate (sucralfate systemic) is a member of the drug class miscellaneous GI agents and is used to treat Duodenal Ulcer, Duodenal Ulcer Prophylaxis, GERD, Hyperphosphatemia of Renal Failure, Stomach Ulcer, Stomatitis and Stress Ulcer Prophylaxis.

US matches:

  • Sucralfate

  • Sucralfate Suspension

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A02BX02

CAS registry number (Chemical Abstracts Service)

0054182-58-0

Chemical Formula

C12-H54-Al16-O75-S8

Molecular Weight

974

Therapeutic Categories

Treatment of peptic ulcer

Protectant of gastrointestinal mucosa

Chemical Name

Sucrose hydrogen sulfate basic aluminium salt

Foreign Names

  • Sucralfatum (Latin)
  • Sucralfat (German)
  • Sucralfate (French)
  • Sucralfato (Spanish)

Generic Names

  • Sucralfate (OS: BAN, USAN, JAN, DCF)
  • Sucralfato (OS: DCIT)
  • CGA-6J (IS)
  • OS 202 (IS)
  • Sucralfate (PH: USP 32, JP XIV)

Brand Names

  • Alfate
    Stadmed, India


  • Alsucral
    Orion, Finland; Orion, Singapore


  • Altsamin
    Taiyo Pharmaceutical, Japan


  • Alusulin
    Teva, Hungary


  • Andapsin
    Orion, Sweden


  • Antepsin
    Baldacci, Italy; Bilim, Turkey; Boehringer Ingelheim, Argentina; Chugai, United Kingdom; Chugai, Ireland; Orion, Denmark; Orion, Finland; Orion, Iceland; Orion, Norway


  • Antepsin (veterinary use)
    Chugai, United Kingdom


  • Apo-Sucralfate
    Apotex, Canada; Apotex, Hong Kong; Apotex, Singapore


  • Bingast
    Nichi-Iko PharmaceuticalJMA, Japan


  • Calfate
    Angelini, Portugal


  • Carafate
    Aspen, Australia; Aspen, New Zealand; Axcan, United States


  • Citogel
    Geymonat, Italy


  • Crafilm
    Francia, Italy


  • Dip
    Merck, Colombia; Merck, Ecuador; Merck, Venezuela


  • Escudo
    Lampugnani, Italy


  • Exinol
    Sankyo, Venezuela


  • Gastalfet
    Beximco, Bangladesh


  • Gastonic
    Nipa, Bangladesh


  • Gastrofait
    E.I.P.I.C.O., Romania; Eipico, United Arab Emirates; Eipico, Bahrain; Eipico, Iraq; Eipico, Jordan; Eipico, Kuwait; Eipico, Lebanon; Eipico, Libya; Eipico, Oman; Eipico, Qatar; Eipico, Saudi Arabia; Eipico, Sudan; Eipico, Yemen


  • Gastrogel
    Giuliani, Italy


  • Inpepsa
    Fahrenheit, Indonesia


  • Iselpin
    Wyeth, Philippines


  • Keal
    EG Labo, Luxembourg


  • Kéal
    EG Labo, France


  • Ketodol (Sucralfate and Ketoprofen)
    Alfa Wassermann, Italy


  • Medgel
    Medicraft, Myanmar


  • Mulcatel
    Maver, Chile


  • Musin
    Otto, Indonesia


  • Muttermin
    Kyowa Yakuhin, Japan


  • Neciblok
    Kalbe, Indonesia


  • Netunal
    Merck, Argentina


  • Nu-Sucralfate
    Nu-Pharm, Canada


  • Ohnesmin
    Tsuruhara Seiyaku, Japan


  • Peptonorm
    Uni-Pharma, Greece


  • Propepsa
    Gracia Pharmindo, Indonesia


  • Regel
    Solitaire, India


  • Regel-SO (Sucralfate and Oxethazaine)
    Solitaire, India


  • Ritaalumin
    Choseido Pharmaceutical, Japan


  • Shualmin
    Sandoz, Japan


  • Sucrabest
    Combustin, Germany; Hexal, Luxembourg


  • Sucrahasan
    Hasan, Vietnam


  • Sucral
    Ranbaxy, Thailand


  • Sucralan
    Lannacher, Austria; Lannacher, Czech Republic; Lannacher, Romania


  • Sucralfaat Katwijk
    Apotex Europe, Netherlands


  • Sucralfaat Merck
    Merck Generics, Netherlands


  • Sucralfaat PCH
    Pharmachemie, Netherlands


  • Sucralfaat ratiopharm
    ratiopharm, Netherlands


  • Sucralfaat Sandoz
    Sandoz, Netherlands


  • Sucralfat Genericon
    Genericon, Austria


  • Sucralfat
    Actavis, Georgia; Medica, Georgia


  • Sucralfate RPG
    RPG, France


  • Sucralfate Teva
    Teva Santé, France


  • Sucralfate
    Eon, United States; Kyowa Yakuhin, Japan; Martec, United States; Pharmaceutical Associates, United States; ratiopharm, United States; Teva USA, United States; Towa Yakuhin, Japan; UDL, United States; Watson, United States


  • Sucralfato ABC
    ABC, Italy


  • Sucralfato Angenerico
    Angenerico, Italy


  • Sucralfato BIG
    Benedetti, Italy


  • Sucralfato Denver
    Denver, Argentina


  • Sucralfato DOC
    DOC Generici, Italy


  • Sucralfato Ecar
    Ecar, Colombia


  • Sucralfato Generis
    Generis, Portugal


  • Sucralfato Merck
    Merck Genéricos, Portugal; Merck Generics, Italy


  • Sucralfato Pliva
    Pliva, Italy


  • Sucralfato Teva
    Teva, Italy


  • Sucralfato
    Synthesis, Colombia


  • Sucralfat-ratiopharm
    Ratiopharm, Germany


  • Sucralfin
    Sanofi-Aventis, Italy


  • Sucralmax
    Quesada, Argentina


  • Sucramal
    Menarini, United Arab Emirates; Menarini, Bahrain; Menarini, Costa Rica; Menarini, Cyprus; Menarini, Dominican Republic; Menarini, Egypt; Menarini, Guatemala; Menarini, Honduras; Menarini, Iraq; Menarini, Jordan; Menarini, Kuwait; Menarini, Lebanon; Menarini, Libya; Menarini, Morocco; Menarini, Nicaragua; Menarini, Panama; Menarini, Qatar; Menarini, Saudi Arabia; Menarini, Sudan; Menarini, El Salvador; Menarini, Syria; Menarini, Yemen; Sanofi-Aventis, Italy


  • Sucramed
    S.Med, Austria


  • Sucrase
    Zydus Cadila, India


  • Sucrassyl
    Paill, Dominican Republic; Paill, Guatemala; Paill, Honduras; Paill, Nicaragua; Paill, Panama; Paill, El Salvador


  • Sucrate
    Jida, China; Lisapharma, Italy; Lisapharma, Thailand


  • Sucroril
    Sofar, Italy


  • Sude
    Lisapharma, China


  • Sugar
    Farma1, Italy


  • Sugast
    SF, Italy


  • Sulcran
    Silesia, Chile; Silesia, Peru


  • Sulcrate
    Axcan, Canada


  • Suril
    Ibirn, Italy


  • Teigast
    Nichi-Iko PharmaceuticalJMA, Japan


  • Tunalmin
    Maeda Yakuhin, Japan


  • Ulcar
    Sanofi Aventis, Tunisia; Sanofi-Aventis, France


  • Ulcefate
    Siam Bheasach, Thailand


  • Ulcefix
    Pharmaghreb, Tunisia


  • Ulcerlmin
    Chugai, Japan


  • Ulcermin
    Bonafarma, Portugal


  • Ulcertec
    DHA, Singapore


  • Ulciram
    Vargas, Venezuela


  • Ulcogant
    Dr. Fisher, Netherlands; Euro, Netherlands; Merck, Austria; Merck, Belgium; Merck, Switzerland; Merck, Costa Rica; Merck, Czech Republic; Merck, Germany; Merck, Dominican Republic; Merck, Guatemala; Merck, Honduras; Merck, Hungary; Merck, Luxembourg; Merck, Nicaragua; Merck, Netherlands; Merck, Panama; Merck, Peru; Merck, El Salvador


  • Ulcon
    Farma, Venezuela


  • Ulcrafate
    Polipharm, Thailand


  • Ulcrast
    B&G, Italy


  • Ulcyte
    Alphapharm, Australia


  • Ulgastran
    Polfa Grodzisk, Poland


  • Ulsafate
    Combiphar, Indonesia


  • Ulsaheal
    Hikma, Oman


  • Ulsanic
    Aspen Pharmacare Consumer, South Africa; Chugai, Hong Kong; Chugai, Thailand; Chugai, Taiwan; Teva, Israel


  • Ulsec
    Asiatic Lab, Bangladesh


  • Ulsicral
    Ikapharmindo, Indonesia


  • Ulsidex
    Dexa Medica, Indonesia


  • Unival
    Senosiain, Mexico


  • Urbal
    Merck, Spain


  • Venter
    Akrihin, Russian Federation; Krka, Czech Republic; Krka, Estonia; Krka, Georgia; Krka, Hungary; Krka, Lithuania; Krka, Latvia; Krka, Romania; Krka, Slovenia; Krka, Slovakia


  • Yuwan
    Sawai Seiyaku, Japan

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, June 1, 2009

Cytotec




In some countries, this medicine may only be approved for veterinary use.


In the US, Cytotec (misoprostol systemic) is a member of the drug class miscellaneous GI agents and is used to treat Abortion, Cervical Ripening, Duodenal Ulcer, Gynecological Conditions, Labor Induction, NSAID-Induced Ulcer Prophylaxis, Postpartum Bleeding and Stomach Ulcer.

US matches:

  • Cytotec

UK matches:

  • Cytotec Tablets (SPC)

Ingredient matches for Cytotec



Misoprostol

Misoprostol is reported as an ingredient of Cytotec in the following countries:


  • Australia

  • Bahrain

  • Belgium

  • Costa Rica

  • Cyprus

  • Denmark

  • Egypt

  • El Salvador

  • Finland

  • France

  • Ghana

  • Greece

  • Guatemala

  • Honduras

  • Hong Kong

  • Iceland

  • Indonesia

  • Ireland

  • Israel

  • Italy

  • Japan

  • Jordan

  • Kenya

  • Kuwait

  • Luxembourg

  • Malaysia

  • Mexico

  • Netherlands

  • New Zealand

  • Nigeria

  • Norway

  • Oman

  • Panama

  • Peru

  • Poland

  • Portugal

  • Saudi Arabia

  • Singapore

  • South Africa

  • Spain

  • Sweden

  • Switzerland

  • Taiwan

  • Thailand

  • Turkey

  • United Arab Emirates

  • United Kingdom

  • United States

  • Venezuela

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, May 23, 2009

Dalsy




Dalsy may be available in the countries listed below.


Ingredient matches for Dalsy



Ibuprofen

Ibuprofen is reported as an ingredient of Dalsy in the following countries:


  • Bosnia & Herzegowina

  • Brazil

  • Croatia (Hrvatska)

  • Spain

International Drug Name Search

Friday, May 15, 2009

Fibro Vein




Fibro-Vein may be available in the countries listed below.


UK matches:

  • Fibro-Vein 3.0%, 1.0%, 0.5%, 0.2% (SPC)

Ingredient matches for Fibro-Vein



Sodium Tetradecyl Sulfate

Sodium Tetradecyl Sulfate is reported as an ingredient of Fibro-Vein in the following countries:


  • Argentina

  • Australia

  • Italy

  • New Zealand

  • Poland

  • South Africa

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, May 14, 2009

CO Metformin




CO Metformin may be available in the countries listed below.


Ingredient matches for CO Metformin



Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of CO Metformin in the following countries:


  • Canada

International Drug Name Search

Wednesday, May 6, 2009

Flunitrazepam-Eurogenerics




Flunitrazepam-Eurogenerics may be available in the countries listed below.


Ingredient matches for Flunitrazepam-Eurogenerics



Flunitrazepam

Flunitrazepam is reported as an ingredient of Flunitrazepam-Eurogenerics in the following countries:


  • Luxembourg

International Drug Name Search

Monday, April 27, 2009

Calbonat




Calbonat may be available in the countries listed below.


Ingredient matches for Calbonat



Calcium

Calcium is reported as an ingredient of Calbonat in the following countries:


  • Bangladesh

International Drug Name Search

Saturday, April 25, 2009

Tirgon




Tirgon may be available in the countries listed below.


Ingredient matches for Tirgon



Bisacodyl

Bisacodyl is reported as an ingredient of Tirgon in the following countries:


  • Germany

International Drug Name Search

Sunday, April 19, 2009

Fosteofos




Fosteofos may be available in the countries listed below.


Ingredient matches for Fosteofos



Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Fosteofos in the following countries:


  • Czech Republic

International Drug Name Search

Saturday, April 11, 2009

Ticlopidina-ratiopharm




Ticlopidina-ratiopharm may be available in the countries listed below.


Ingredient matches for Ticlopidina-ratiopharm



Ticlopidine

Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Ticlopidina-ratiopharm in the following countries:


  • Italy

  • Portugal

  • Spain

International Drug Name Search

Saturday, April 4, 2009

Promethacon




Ingredient matches for Promethacon



Promethazine

Promethazine hydrochloride (a derivative of Promethazine) is reported as an ingredient of Promethacon in the following countries:


  • United States

International Drug Name Search

Tuesday, March 24, 2009

Angiazem




Angiazem may be available in the countries listed below.


Ingredient matches for Angiazem



Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Angiazem in the following countries:


  • Serbia

International Drug Name Search

Saturday, March 14, 2009

Lisinomerck




Lisinomerck may be available in the countries listed below.


Ingredient matches for Lisinomerck



Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinomerck in the following countries:


  • Japan

International Drug Name Search

Saturday, February 21, 2009

Gelliprim




Gelliprim may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Gelliprim



Sulfadiazine

Sulfadiazine is reported as an ingredient of Gelliprim in the following countries:


  • Italy

Trimethoprim

Trimethoprim is reported as an ingredient of Gelliprim in the following countries:


  • Italy

International Drug Name Search

Sunday, February 15, 2009

Oxéladine




Oxéladine may be available in the countries listed below.


Ingredient matches for Oxéladine



Oxeladin

Oxéladine (DCF) is also known as Oxeladin (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

bethanechol


Generic Name: bethanechol (be THAN e chol)

Brand Names: Duvoid, Urecholine


What is bethanechol?

Bethanechol stimulates your bladder to empty.


Bethanechol is used to treat urinary retention (difficulty urinating), which may occur after surgery, after delivering a baby, and in other situations.


Bethanechol may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about bethanechol?


Take bethanechol on an empty stomach 1 hour before or 2 hours after meals to prevent nausea and vomiting. Bethanechol may cause dizziness or fainting, especially when you rise from a sitting or lying position. Rise slowly to avoid becoming dizzy, falling, or hurting yourself.

Use caution when driving, operating machinery, or performing other hazardous activities. Bethanechol may cause dizziness. If you experience dizziness, avoid these activities.


What should I discuss with my healthcare provider before taking bethanechol?


Before taking this medication, tell your doctor if you



  • have uncontrolled hyperthyroidism (an overactive thyroid);




  • have stomach ulcers;




  • have asthma;




  • have recently had bladder or intestinal surgery;




  • have a blockage in your intestinal tract;




  • have a slow heart rate or low blood pressure;




  • have a disease or blockage of the arteries in your heart (coronary artery disease);




  • have epilepsy or any other seizure disorder; or




  • have Parkinson's disease.



You may not be able to take bethanechol, or you may require a lower dose or special monitoring during treatment if you have any of the conditions listed above.


Bethanechol is in the FDA pregnancy category C. This means that it is not known whether bethanechol will harm an unborn baby. Do not take this medication without first talking to your doctor if you are pregnant. It is not known whether bethanechol passes into breast milk. Do not take this medication without first talking to your doctor if you are breast-feeding a baby.

How should I take bethanechol?


Take bethanechol exactly as directed by your doctor. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.


Take each dose with a full glass of water. Take bethanechol on an empty stomach 1 hour before or 2 hours after meals to prevent nausea and vomiting. Store bethanechol at room temperature away from moisture and heat.

See also: Bethanechol dosage (in more detail)

What happens if I miss a dose?


Take the missed dose as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and take only your next regularly scheduled dose. Do not take a double dose of this medication.


What happens if I overdose?


Seek emergency medical attention.

Symptoms of a bethanechol overdose include abdominal discomfort, increased salivation or watering mouth, flushing or hot feeling of the skin, sweating, nausea, and vomiting.


What should I avoid while taking bethanechol?


Bethanechol may cause dizziness or fainting, especially when you rise from a sitting or lying position. Rise slowly to avoid becoming dizzy, falling, or hurting yourself.

Use caution when driving, operating machinery, or performing other hazardous activities. Bethanechol may cause dizziness. If you experience dizziness, avoid these activities.


Bethanechol side effects


If you experience any of the following serious side effects, stop taking bethanechol and seek emergency medical attention:

  • an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives); or




  • shortness of breath, wheezing, or tightness in your chest.



Other, less serious side effects may be more likely to occur. Continue to take bethanechol and talk to your doctor if you experience



  • dizziness or drowsiness;




  • headache;




  • nausea, vomiting, diarrhea, or abdominal discomfort;




  • slow heartbeats followed by fast heartbeats;




  • flushing or warmth about the face;




  • sweating; or




  • tearing eyes.



Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.


Bethanechol Dosing Information


Usual Adult Dose for Urinary Retention:

Oral: 10 to 50 mg 3 to 4 times a day.

Subcutaneous: 2.5 to 5 mg 3 to 4 times a day. Doses up to 7.5 to 10 mg every 4 hours have been used for neurogenic bladder. Such large doses may cause severe reactions and should only be used after adequate trial of single doses (2.5 to 5 mg) has established that smaller doses are not sufficient.

Usual Pediatric Dose for Urinary Retention:

The safety and efficacy of bethanechol in pediatric patients has not been established. However, bethanechol may be appropriate for use in some situations.

Oral:
>1 year: 0.6 mg/kg/day divided 3 to 4 times a day.
Subcutaneous: 0.12 to 2 mg/kg/day divided 3 to 4 times a day.

Usual Pediatric Dose for Gastroesophageal Reflux Disease:

The safety and efficacy of bethanechol in pediatric patients has not been established. However, bethanechol may be appropriate for use in some situations

Oral:
>1 year: 0.1 to 0.2 mg/kg/dose 30 minutes to 1 hour before meals and at bedtime to a maximum of 4 times a day.

Usual Pediatric Dose for Abdominal Distension:

The safety and efficacy of bethanechol in pediatric patients has not been established. However, bethanechol may be appropriate for use in some situations.

Oral:
>1 year: 0.6 mg/kg/day divided 3 to 4 times a day.
Subcutaneous: 0.12 to 2 mg/kg/day divided 3 to 4 times a day.


What other drugs will affect bethanechol?


Before taking bethanechol, tell your doctor if you are taking any of the following medicines:



  • donepezil (Aricept);




  • tacrine (Cognex);




  • quinidine (Cardioquin, others); or




  • procainamide (Pronestyl, Procan SR).



You may not be able to take bethanechol, or you may require a dosage adjustment or special monitoring during treatment if you are taking any of the medicines listed above.


Drugs other than those listed here may also interact with bethanechol. Talk to your doctor and pharmacist before taking or using any other prescription or over-the-counter medicines.



More bethanechol resources


  • Bethanechol Side Effects (in more detail)
  • Bethanechol Dosage
  • Bethanechol Use in Pregnancy & Breastfeeding
  • Drug Images
  • Bethanechol Drug Interactions
  • Bethanechol Support Group
  • 1 Review for Bethanechol - Add your own review/rating


  • bethanechol Oral, Subcutaneous Advanced Consumer (Micromedex) - Includes Dosage Information

  • Bethanechol MedFacts Consumer Leaflet (Wolters Kluwer)

  • Bethanechol Prescribing Information (FDA)

  • Bethanechol Chloride Monograph (AHFS DI)

  • Urecholine Prescribing Information (FDA)



Compare bethanechol with other medications


  • Abdominal Distension
  • GERD
  • Urinary Retention


Where can I get more information?


  • Your pharmacist has more information about bethanechol written for health professionals that you may read.

See also: bethanechol side effects (in more detail)


Monday, February 9, 2009

Loratadina Hexal




Loratadina Hexal may be available in the countries listed below.


Ingredient matches for Loratadina Hexal



Loratadine

Loratadine is reported as an ingredient of Loratadina Hexal in the following countries:


  • Italy

International Drug Name Search

Friday, February 6, 2009

Amlodipina Amlocor




Amlodipina Amlocor may be available in the countries listed below.


Ingredient matches for Amlodipina Amlocor



Amlodipine

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Amlodipina Amlocor in the following countries:


  • Portugal

International Drug Name Search